Shan-shan H. Lu
Changsha, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Influence of USP15 and its derived-peptide on non-small cell lung cancer immune evasion via regulating PD-L1 stability.
Journal: Journal for immunotherapy of cancer
Published: March 13, 2026
PRMT5 Methylates and Stabilizes EphA2 via Inhibiting Its Ubiquitination and Degradation to Promote Nasopharyngeal Carcinoma Stem Cell Properties.
Journal: MedComm
Published: August 23, 2025
ANXA1-Derived Peptide Increases Melanoma Cell Sensitivity to Vemurafenib by Downregulating EphA2.
Journal: Journal of cellular and molecular medicine
Published: July 31, 2025
A11 Peptide Enhances Radiosensitivity by Degrading EphA2 in Nasopharyngeal Carcinoma.
Journal: Cancer science
Published: July 21, 2025
Retraction Note: Annexin A1-suppressed autophagy promotes nasopharyngeal carcinoma cell invasion and metastasis by PI3K/AKT signaling activation.
Journal: Cell death & disease
Published: March 20, 2025
FVTF inhibits hepatocellular carcinoma stem properties via targeting DNMT1/miR-34a-5p/FoxM1 axis.
Journal: Chinese medicine
Published: November 18, 2024
ANXA1 Binds and Stabilizes EGFR to Promote Nasopharyngeal Carcinoma Radioresistance.
Journal: Molecular cancer therapeutics
Published: October 22, 2024
USP5 Binds and Stabilizes EphA2 to Increase Nasopharyngeal Carcinoma Radioresistance.
Journal: International journal of biological sciences
Published: August 17, 2024
ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers.
Journal: Journal for immunotherapy of cancer
Published: March 14, 2023
ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating Stat3-Induced Expression of PD-L1 in Multiple Cancers.
Journal: Cancer immunology research
Published: November 14, 2022
ANXA1 Binds and Stabilizes EphA2 to Promote Nasopharyngeal Carcinoma Growth and Metastasis.
Journal: Cancer research
Published: February 18, 2020
ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
Journal: International journal of oncology
Published: February 08, 2020
Last Updated: 09/26/2026